PHC Launches LiCellMoTM Live Cell Metabolic Analyzer for Real-Time Visualization of Cellular Metabolism in Cell and Gene Therapies

TOKYO -- PHC Corporation Biomedical Division (headquarters: Chiyoda-ku, Tokyo, President: Nobuaki Nakamura; hereafter Biomedical Division) announced today the commercial launch of LiCellMo, a live cell metabolic analyzer that allows researchers to visualize metabolic^(*1) changes in cell cultures, providing a more complete picture of cell activity for research uses in cell and gene therapies (CGT). LiCellMo uses PHC’s proprietary high-precision In-Line monitoring technology^(*2), which enables continuous measurement of cellular metabolites in culture medium without needing to interrupt the experiment for sampling. LiCellMo will be launched in Japan in September, followed by a launch in other select geographies in October. Read More